Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate
Condition(s):Postmenopausal OsteoporosisLast Updated:June 5, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Postmenopausal OsteoporosisLast Updated:June 5, 2013Completed
Condition(s):Osteoporosis; Prostate CancerLast Updated:December 7, 2016Completed
Condition(s):OsteoporosisLast Updated:December 16, 2011Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:June 6, 2018Completed
Condition(s):Osteoporosis; Muscular Dystrophy; Cystic FibrosisLast Updated:January 9, 2018Completed
Condition(s):OsteopeniaLast Updated:April 8, 2013Terminated
Condition(s):Esophageal Cancer; Squamous Cell Carcinoma; AdenocarcinomaLast Updated:February 3, 2022Completed
Condition(s):Suicidal Ideation; InteroceptionLast Updated:April 25, 2022Completed
Condition(s):Postmenopausal OsteoporosisLast Updated:February 15, 2019Completed
Condition(s):Ankylosing SpondylitisLast Updated:May 8, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.